((自动化翻译由路透提供,请见免责声明 ))
路透10月24日 - 医疗设备制造商Dexcom 周四公布的第三季度营收超过了华尔街预期,这主要得益于糖尿病患者对其连续血糖监测仪的强劲需求。
然而,该公司重申其全年销售额预期约为40亿美元至40.5亿美元,导致其股价在收盘后下跌近16%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.